RA Capital Nexus Fund III, Director: Mineralys Therapeutics MLYS Buy · Filed 03/31

Trade details

Type: Insider buy
Amount: $7,354,269
Shares · price: 310,700 sh · $23.67 a share
Held after: 5,767,221 sh
Stock: Mineralys Therapeutics MLYS
Person: RA Capital Nexus Fund IIIDirector
Trade date: 26/03/27
Filed: 26/03/31
Days to filing: 4 days

First buy since 2023

Insiders buying this week: 5 insiders
Holding change: +5.7%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 02/25~04/26

RA Capital Nexus Fund III's recent trades

RA Capital Nexus Fund IIIDirector
Planned saleSepterna
Planned sale
Septerna
SEPN
$36M
746,500 sh
$36M
Filed 08/12
Traded 08/12
RA Capital Nexus Fund IIIDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$275.3K
31,000 sh
$275.3K
Filed 06/29
Traded 06/25
RA Capital Nexus Fund IIIDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$16.8K
1,876 sh
$16.8K
Filed 06/29
Traded 06/26
RA Capital Nexus Fund IIIDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$3.4M
391,019 sh
$3.4M
Filed 06/16
Traded 06/12
RA Capital Nexus Fund IIIDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$1.1M
124,893 sh
$1.1M
Filed 06/16
Traded 06/16

RA Capital Nexus Fund III, Director — bought $7.4M of Mineralys Therapeutics MLYS · 310,700 sh @ $23.67 | Whalegun